Objective-To evaluate the effectiveness and safety of percutaneous balloon mitral commissurotomy for the treatment of pregnant women with severe mitral stenosis over a period of six years.
in Monastir, Tunisia. Patients-44 pregnant patients who underwent percutaneous transvenous dilatation of the mitral valve between January 1990 and February 1996. Grade 2 mitral regurgitation was present in two patients and densely calcific valves in three (7%). Results-Commissurotomy was successfully achieved in all cases. The total mean (SD) duration of the procedure was 72 (18) minutes and that of fluoroscopy 16 (7) minutes. Left atrial pressure decreased from 28 (10) to 14 (7) mm Hg, mitral pressure gradient fell from 22 (8) Complications included a grade 4 mitral regurgitation in one patient that required early valve replacement. All patients delivered at full term, 42 vaginally and two (5%) by caesarean section; 41 babies were normal and three whose mothers had the procedure near term were relatively hypotrophic. At a mean follow up of 28 (12) 26 (6) weeks. Forty patients (91 %) were in sinus rhythm and the remaining four were in atrial fibrillation. Four patients had a previous surgical commissurotomy and four others had a previous balloon mitral commissurotomy. Despite medical treatment including bed rest, frusemide, and digoxin (only two patients who had uncontrolled heart rate with digitalis were given atenolol), 15 patients (34%) remained in New York Heart Association (NYHA) functional class IV and 25 patients (57%) in class III. The four remaining patients initially had severe disability that improved to functional class II. Two of them had an echo mitral valve area (MVA) of 1 0 cm2 and 1 2 cm2, respectively. In the two others who had an echo MVA of 1 4 and 1-5 cm2, respectively, the procedure was undertaken because of a history of spontaneous miscarriage during the third trimester of previous pregnancies. In four patients, the procedure had to be performed within 48 hours of admission because of severe refractory pulmonary oedema.
ECHOCARDIOGRAPHIC STUDY
Cross sectional, pulsed, colour, and continuous wave Doppler echocardiographic examinations were performed 24 hours before and 24 hours after balloon mitral commissurotomy, and at four to six month intervals of fol-Percutaneous balloon mitral commissurotomy during pregnancy NYHA, New York Heart Association grade; pre/post, before/after commissurotomy. All patients, including the one who received early mitral valve replacement, had a substantial functional improvement which allowed discontinuation of diuretics in all but the four patients with grade 2 mitral regurgitation. Digoxin was continued in those four patients and in the four patients with atrial fibrillation. Acenocoumarol was given until the 37th week of gestation to the four patients in atrial fibrillation and to the patient who received mitral valve replacement; after this it was replaced by subcutaneous heparin. The 44 women all had a spontaneous full term delivery, vaginally in 42 and by caesarean section in two for obstetrical reasons. The 44 newborn babies were healthy, without any evidence of fetal abnormality caused by radiation. Mean body weight of the babies was 3-2 (0-45) kg, range 2-0 to 4-4. Three women who underwent balloon mitral commissurotomy late in pregnancy (after the 30th week of gestation) delivered hypotrophic babies (body weight between 2 and 2-5 kg).
At a mean follow up of 30 (16) months (range 6 to 72), 40 patients (91%) remained in functional class I, three patients were in class II, and one patient with a severely calcified valve returned to class IV, with severe mitral stenosis which required mitral valve replacement. Overall, MVA as assessed by cross sectional echo decreased from 2-32 (0 36) to [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] (0A40) cm2 (P < 0-05 ). At a mean postpartum follow up of 28 (12) reports'2-22 documenting about 100 cases, only one included 19 patients.'8 For the best of our knowledge, our series is the largest reported with complete pre-and postprocedural haemodynamic assessment. As reported in these other studies, in our series balloon mitral commissurotomy produced impressive haemodynamic improvement including a decrease in left atrial and pulmonary artery pressures, a fall in pulmonary and systemic vascular resistance, and an increase in cardiac output and mitral valve area.
One of the crucial changes that affects the subsequent course of gestation is likely to be the significant increase in cardiac output (1.5 1/min in this study). Most of our patients had a pliable mitral valve with mild or no mitral regurgitation, which represent the ideal anatomy for balloon mitral commissurotomy. With the benefit of the experience we have acquired, we broadened our indications to include three patients with a densely calcified mitral valve and two with a pliable mitral valve but with a grade 2 mitral regurgitation. Very satisfactory results were obtained in all those five cases. Other large studies3-'2 including our own have also reported satisfactory results in many patients with calcific valves. With respect to grade 2 mitral regurgitation, although this remained unchanged in our two patients, we believe that in such cases balloon mitral commissurotomy should be performed with great caution and with adequate surgical back up.
Very few complications have been reported with balloon mitral commissurotomy during pregnancy. New severe mitral regurgitation occurred in only one patient of our series, who underwent a successful prosthetic mitral valve replacement. In one report, one patient had a spontaneous abortion.20 Occasionally'719 ominous hypotension requiring administration of drugs and fluids occurred. A left to right interatrial shunt was more common, but it was too small to have any immediate or late consequences. There were no maternal deaths in our series or in the previous reports.'2 22 In contrast, mortality from surgical closed mitral commissurotomy was as high as 3%24-26 and that from open commissurotomy reached 5% 27 30 EFFECT OF BALLOON MITRAL COMMISSUROTOMY ON PREGNANCY OUTCOME Highly significant functional improvement paralleled haemodynamic improvement in all patients: frusemide was discontinued in 90% of patients and digoxin in 81 %. Forty patients returned to class I and four to class II. Uneventful full term delivery was obtained in all patients, vaginally in 42; caesarean section was required in only two patients (5%) for obstetric reasons. The relative growth retardation in three newborns probably reflected the lateness of the procedure in these cases, but this needs further investigation to be confirmed.
There were no fetal deaths or preterm deliveries in our series. However, in previous studies, three neonatal fatalities have been reported; all three were related to particular circumstances: a premature birth,'5 an obstetric factor,'9 and a gemellar pregnancy.20
Following surgical closed mitral commissurotomy,24-26 the prematurity rate varied from 10% up to 37%, and fetal mortality ranged from 0% up to 15%. Open heart commissurotomy carries a higher risk of 20-30% fetal wastage. [27] [28] [29] [30] Fluoroscopic radiation exposure carries a potential risk to the unborn child. However, the risk is greatly diminished by appropriate and complete abdominal lead shielding, a short radiation exposure time, avoidance of left ventricular angiography, and performance of the procedure after the 14th week of gestation, when organogenesis has already been achieved. In previous reports, as in our own, no baby had abnormalities related to radiation.
The double balloon technique was used in most of our patients and the Inoue balloon, which was not available in our shorter fluoroscopy time but they did not record the haemodynamic measurements which certainly contribute to the shortening of the procedure. The total radiation dose has sometimes been estimated13 19 and has always been lower than 0-2 rads, far below the dose at which therapeutic abortion can legally be carried out. It is noteworthy that the 44 infants in this study had normal growth and mental development at an intermediate follow up. Twenty children are now 3 to 5 years old and are in excellent health. As yet, however, the long term outcome in these children remains unknown, since the future late appearance of radiation side effects cannot be excluded, though it must be very unlikely. Griem et al,3 in a 20 year follow up study of 1000 women irradiated for radiopelvimetry at much higher doses (15 to 30 mSv), found no difference in the incidence of cancer in comparison with a control group.
MEDICAL TREATMENT FOR MITRAL STENOSIS DURING PREGNANCY
Although medical treatment is always recommended as first line therapy of mitral stenosis during pregnancy before considering balloon mitral commissurotomy, the untoward effects of some drugs in this particular setting should be borne in mind.
Diuretics, which are very effective, are known on the other hand to decrease placental perfusion and therefore are not recommended during pregnancy.31 P Blockers, which can be very beneficial during pregnancy,33 also carry some risk, particularly in patients with severe pulmonary hypertension and low cardiac output. Some studies have failed to show any clear benefit of ,B blockers in non-pregnant patients with mitral stenosis,34 35 while others32 have reported serious adverse effects on the fetus and neonate (intrauterine growth retardation, bradycardia, hypoglycaemia, hyperbilirubinaemia) with the use of these agents during pregnancy. Thus balloon commissurotomy seems to be an excellent alternative to drug treatment. However, until greater experience is acquired, balloon mitral commissurotomy during pregnancy should be confined to patients with severe mitral stenosis who are refractory to optimum medical treatment.
Note added in proof: Since this paper was submitted, we have successfully performed six more balloon mitral commissurotomies during pregnancy.
